What are the general treatment recommendations for acute myeloid leukemia (AML)?

Updated: Dec 05, 2018
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


Fit patients (< 60-65 years, select patients up to age 75 y) receive intensive therapy. Treatment includes induction therapy and postremission therapy (consolidation). Non–low-risk patients are evaluated for stem cell transplantation in first remission.

Less-fit patients (70-75 years and older, or younger patients with significant comorbidities) receive low-intensity therapy. Select less-fit patients with highly proliferative disease may be considered for intensive therapy

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!